Saudi Pharmaceutical Industries and Medical Appliances Corporation

2070.SRSAUHealthcare● Active

$28.50

$-0.40(-1.38%)

Market Cap$3.4B

P/E Ratio—

52W High$33.12

52W Low$22

Avg Volume639K

Open$29.00

Beta0.40

Cash on Hand Financials Revenue

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

2070.SR · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$384.4M▲ +38.5% vs prior year

FY · as of Dec 31, 2025 · Reported in SAR

Cash & Cash Equiv. (CCE)

$203.9M

cashAndCashEquivalents

Short-Term Investments

$180.5M

shortTermInvestments

YoY Change vs Prior Year

+38.5%

vs prior fiscal year

Latest Quarter

$341.6M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$384.4MCash on Hand

Total Debt$1.43BTotal Debt

Net Cash / Net Debt−$1.05BNet Debt Position

Cash vs Debt Ratio

Cash 21%Saudi Pharmaceutical Industries and Medical Appliances Corporation cash as % of market cap: 11.30%% · MCap $3BDebt 79%

Saudi Pharmaceutical Industries and Medical Appliances Corporation carries a net debt position of $1.05B. Total debt ($1.43B) exceeds cash on hand ($384.4M). Saudi Pharmaceutical Industries and Medical Appliances Corporation cash vs debt ratio: 21% cash / 79% debt.

Net Cash = Cash & ST Investments − Total Debt$384.4M − $1.43B = −$1.05B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

2070.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

2070.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$384.4M+38.5%

Dec 31, 2024FY$277.6M+0.6%

Dec 31, 2023FY$276.0M-27.5%

Dec 31, 2022FY$380.8M-57.5%

Dec 31, 2021FY$896.0M-16.6%

2070.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

2070.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Saudi Pharmaceutical Industries and Medical Appliances CorporationYOU

2070.SR

$384.4M$3B11.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) cash on hand as of December 31, 2025 is $384.4M, comprising $203.9M in cash and cash equivalents (CCE) plus $180.5M in short-term investments — reported as Saudi Pharmaceutical Industries and Medical Appliances Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Saudi Pharmaceutical Industries and Medical Appliances Corporation cash reserves or cash position.

Saudi Pharmaceutical Industries and Medical Appliances Corporation annual cash on hand history shows increased +38.5% in 2025: increased +38.5% in 2025. Saudi Pharmaceutical Industries and Medical Appliances Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Saudi Pharmaceutical Industries and Medical Appliances Corporation carries total debt of $1.43B against cash of $384.4M, resulting in a net debt position of -$1.05B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

2070.SR cash on hand · 5 questions

As of December 31, 2025, Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) has $384,382,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $203,906,000 in cash and cash equivalents (CCE) plus $180,476,000 in short-term investments. Latest quarter (March 31, 2026): $341,604,000. Data sourced from the annual 10-K filing via FMP.

2070.SR cash on hand2070.SR cash reserves2070.SR cash 2025how much cash does 2070.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Saudi Pharmaceutical Industries and Medical Appliances Corporation · Saudi Pharmaceutical Industries and Medical Appliances Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025